The Cancer Moonshot, the role of in vitromodels, model accuracy, and the needfor validation

Peter C. Searson discusses how reducing cancer-related deaths can only happen with a better understanding of cancer biology and the development of improved, new therapeutics and delivery mechanisms. Nearly all cancer research is dependent upon the models being used, the model’s accuracy, and appropriate validation and benchmarking. Here the need for such considerations is discussed in line with the goal of the Cancer Moonshot.

Read more at https://www.nature.com/articles/s41565-023-01486-0